About ASSO International Consulting
ASSO regards each project as the best communication bridge between us and our customers. ASSO solemnly promises that ASSO will treat each project as our most important customer project.
Global Intravenous Immunoglobulin (IVIg) Treatment Report 20
IVIG, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of IVIG. While this is a blood product, IVIG available in the United States, is purified and carefully screened to be free of all known transmissible diseases, including HIV, hepatitis, malaria, syphilis and many, many others. This medication is used to treat a variety of neurological and neuromuscular autoimmune disorders that affect the central nervous system, peripheral nerves, neuromuscular junction and muscles.
The global intravenous immunoglobulin market is divided into hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy, immunodeficiency diseases, myasthenia gravis, multifocal motor neuropathy, idiopathic thrombocytopenic purpura, inflammatory myopathies, specific antibody deficiency, Guillain-Barre syndrome, and others. The hypogammaglobulinemia segment was the highest contributor to the market in 2018, and is anticipated to maintain its dominance throughout the forecast period. This is attributed to the significant rise in the prevalence of hypogammaglobulinemia disorder across the globe over the years. For instance, hypogammaglobulinemia is the most common chronic immune defect in patients with lymphoproliferative disorders (LPDs). Its incidence rate is ~2 per 100,000 population yearly, globally.
In the past few years, IFF analysts have pointed out that the IVIg industry has maintained a steady growth rate. With the development of industry, various chemical raw materials, water pollution, radiation and other potential factors continue to threaten people's health, especially in developing countries. However, people's pursuit of healthy living has made the industry grow. In 2020, the market size of global is estimated to be xxx million USD. The IFF analysis team predicts that in 2025, the market size of global will reach xxx million USD. During the forecast period of 2021-2025, the market size of global Intravenous Immunoglobulin (IVIg) Treatment will increase by XX%.
Order the report and sample
sales@assointernationalconsulting.com
contact@assointernationalconsulting.com
ASSO regards each project as the best communication bridge between us and our customers. ASSO solemnly promises that ASSO will treat each project as our most important customer project. We will go all out and never give up. ASSO regards each other's excellence as the purpose of our service. ASSO's services involve regional analysis, market data, player share, market decision-making, marketing and product positioning
– Allen King
Leave a comment
All fields marked with an asterisk (*) are required